Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression
- 1 January 2008
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 122 (6) , 854-860
- https://doi.org/10.1016/j.thromres.2008.02.010
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Role of angiotensin-converting enzyme insertion/deletion and plasminogen activator inhibitor-1 4G/5G gene polymorphisms in retinal vein occlusionJournal of Thrombosis and Haemostasis, 2005
- Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of StrokeStroke, 2005
- A role for the fibrinolytic system in postsurgical adhesion formationFertility and Sterility, 2005
- Plasminogen activators and plasminogen activator inhibitors in endometriosisFrontiers in Bioscience-Landmark, 2005
- Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertensionCardiovascular Research, 2004
- In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissueMolecular Human Reproduction, 2004
- Urokinase‐Type Plasminogen Activator and Insulin‐Like Growth Factor‐Binding Protein 3 mRNA Expression in Endometriotic Lesions and Eutopic EndometriumAnnals of the New York Academy of Sciences, 2003
- Endometrial Quality in Infertile Women with EndometriosisAnnals of the New York Academy of Sciences, 2001
- Clinical Relevance of the Plasminogen Activator Inhibitor Type1 – a Multifaceted Proteolytic FactorOncology Research and Treatment, 2001
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996Fertility and Sterility, 1997